These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26397259)

  • 1. The Current Means for Detection of Migraine Headache Trigger Sites.
    Guyuron B; Nahabet E; Khansa I; Reed D; Janis JE
    Plast Reconstr Surg; 2015 Oct; 136(4):860-867. PubMed ID: 26397259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of outcome of surgical treatment of migraine headaches using a constellation of symptoms versus botulinum toxin type A to identify the trigger sites.
    Liu MT; Armijo BS; Guyuron B
    Plast Reconstr Surg; 2012 Feb; 129(2):413-419. PubMed ID: 21987048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effectiveness of Peripheral Nerve Blocks for Diagnosis of Migraine Trigger Points.
    Rangwani SM; Hehr JC; Janis JE
    Plast Reconstr Surg; 2021 Dec; 148(6):992e-1000e. PubMed ID: 34847126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Positive and Negative Predictive Value of Targeted Diagnostic Botox Injection in Nerve Decompression Migraine Surgery.
    ElHawary H; Kavanagh K; Janis JE
    Plast Reconstr Surg; 2024 May; 153(5):1133-1140. PubMed ID: 37285182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year outcome of surgical treatment of migraine headaches.
    Guyuron B; Kriegler JS; Davis J; Amini SB
    Plast Reconstr Surg; 2011 Feb; 127(2):603-608. PubMed ID: 20966820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A placebo-controlled surgical trial of the treatment of migraine headaches.
    Guyuron B; Reed D; Kriegler JS; Davis J; Pashmini N; Amini S
    Plast Reconstr Surg; 2009 Aug; 124(2):461-468. PubMed ID: 19644260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive botulinum toxin type a response is a prognosticator for migraine surgery success.
    Lee M; Monson MA; Liu MT; Reed D; Guyuron B
    Plast Reconstr Surg; 2013 Apr; 131(4):751-757. PubMed ID: 23542247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine Trigger Site Surgery is All Placebo.
    McGeeney BE
    Headache; 2015; 55(10):1461-3. PubMed ID: 26473329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of surgical decompression to relieve migraine headaches.
    Poggi JT; Grizzell BE; Helmer SD
    Plast Reconstr Surg; 2008 Jul; 122(1):115-122. PubMed ID: 18594393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trigger areas nerve decompression for refractory chronic migraine.
    Chen G; You H; Juha H; Lou B; Zhong Y; Lian X; Peng Z; Xu T; Yuan L; Woralux P; Hugo AB; Jianliang C
    Clin Neurol Neurosurg; 2021 Jul; 206():106699. PubMed ID: 34053808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-Depth Review of Symptoms, Triggers, and Treatment of Occipital Migraine Headaches (Site IV).
    Ascha M; Kurlander DE; Sattar A; Gatherwright J; Guyuron B
    Plast Reconstr Surg; 2017 Jun; 139(6):1333e-1342e. PubMed ID: 28538577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The surgical management of cephalalgia.
    Osborn TM
    Curr Opin Otolaryngol Head Neck Surg; 2016 Aug; 24(4):359-67. PubMed ID: 27138357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the peripheral trigger point theory of migraine headaches: single-surgeon experience using botulinum toxin and surgical decompression.
    Janis JE; Dhanik A; Howard JH
    Plast Reconstr Surg; 2011 Jul; 128(1):123-131. PubMed ID: 21701329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine headache trigger site prevalence analysis of 2590 sites in 1010 patients.
    Seyed Forootan NS; Lee M; Guyuron B
    J Plast Reconstr Aesthet Surg; 2017 Feb; 70(2):152-158. PubMed ID: 27931736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonendoscopic deactivation of nerve triggers in migraine headache patients: surgical technique and outcomes.
    Gfrerer L; Maman DY; Tessler O; Austen WG
    Plast Reconstr Surg; 2014 Oct; 134(4):771-778. PubMed ID: 24945947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Long-Term, Targeted OnabotulinumtoxinA versus Peripheral Trigger Site Deactivation Surgery for the Treatment of Refractory Migraine Headaches.
    Schoenbrunner AR; Khansa I; Janis JE
    Plast Reconstr Surg; 2020 Feb; 145(2):401e-406e. PubMed ID: 31985655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Pain Sketches Can Predict Surgical Outcomes in Trigger-Site Deactivation Surgery for Headaches.
    Gfrerer L; Hansdorfer MA; Ortiz R; Nealon KP; Chartier C; Runyan GG; Zarfos SD; Austen WG
    Plast Reconstr Surg; 2020 Oct; 146(4):863-871. PubMed ID: 32970009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth review of symptoms, triggers, and treatment of temporal migraine headaches (Site II).
    Kurlander DE; Punjabi A; Liu MT; Sattar A; Guyuron B
    Plast Reconstr Surg; 2014 Apr; 133(4):897-903. PubMed ID: 24675192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical treatment of migraine headaches.
    Gfrerer L; Guyuron B
    Acta Neurol Belg; 2017 Mar; 117(1):27-32. PubMed ID: 28013487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic migraine headache with onabotulinumtoxinA.
    Gerwin R
    Curr Pain Headache Rep; 2011 Oct; 15(5):336-8. PubMed ID: 21547527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.